WAY-362450 5mg 5mg | Purity Not Available
Adooq Bioscience
WAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageWAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageWAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageWAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageWAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageRibitol is a crystalline pentose alcohol formed by the reduction of ribose.
More Information Supplier PageRibitol is a crystalline pentose alcohol formed by the reduction of ribose.
More Information Supplier PageClinofibrate is a lipid clearing agent that appears to modify lipid metabolism, diminishing the steroid induced accumulation of lipids within osteocytes. It also can effectively reduce the plasma fibrinogen level.
More Information Supplier PageClinofibrate is a lipid clearing agent that appears to modify lipid metabolism, diminishing the steroid induced accumulation of lipids within osteocytes. It also can effectively reduce the plasma fibrinogen level.
More Information Supplier PageWYE-687 is a novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin(mTOR).
More Information Supplier PageWYE-687 is a novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin(mTOR).
More Information Supplier Page